Charter Medical to be the Exclusive Distributor for CELLution Biotech in North America and the European Union
2/22/2013 11:50:35 AM
MANCHESTER, Conn., Feb. 22, 2013 (GLOBE NEWSWIRE) -- Charter Medical, Ltd., a Lydall subsidiary, (NYSE:LDL) announced today that it has established a strategic partnership with CELLution Biotech B.V., an innovative developer and provider of bioreactors and fermenters based in the Netherlands. By combining their respective expertise in single-use technology and mass transfer, the partnership will provide customers in North America and Europe with turnkey single-use solutions for fermentation and perfusion cell growth.
comments powered by